Skip to Content
Merck
  • Replication of Merkel cell polyomavirus induces reorganization of promyelocytic leukemia nuclear bodies.

Replication of Merkel cell polyomavirus induces reorganization of promyelocytic leukemia nuclear bodies.

The Journal of general virology (2016-09-02)
Friederike Neumann, Manja Czech-Sioli, Thomas Dobner, Adam Grundhoff, Sabrina Schreiner, Nicole Fischer
ABSTRACT

Merkel cell polyomavirus (MCPyV) is associated with Merkel cell carcinoma (MCC), a rare but aggressive skin cancer. The virus is highly prevalent: 60-80 % of adults are seropositive; however, cells permissive for MCPyV infection are unknown. Consequently, very little information about the MCPyV life cycle is available. Until recently, MCPyV replication could only be studied using a semi-permissive in vitro replication system (Neumann et al., 2011; Feng et al., 2011, Schowalter et al., 2011). MCPyV replication most likely depends on subnuclear structures such as promyelocytic leukemia protein nuclear bodies (PML-NBs), which are known to play regulatory roles in the infection of many DNA viruses. Here, we investigated PML-NB components as candidate host factors to control MCPyV DNA replication. We showed that PML-NBs change in number and size in cells actively replicating MCPyV proviral DNA. We observed a significant increase in PML-NBs in cells positive for MCPyV viral DNA replication. Interestingly, a significant amount of cells actively replicating MCPyV did not show any Sp100 expression. While PML and Daxx had no effect on MCPyV DNA replication, MCPyV replication was increased in cells depleted for Sp100, strongly suggesting that Sp100 is a negative regulator of MCPyV DNA replication.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Daxx Antibody, serum, Upstate®